Literature DB >> 22357347

The μ-opioid receptor in cancer progression: is there a direct effect?

Frances E Lennon1, Jonathan Moss, Patrick A Singleton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22357347     DOI: 10.1097/ALN.0b013e31824b9512

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  31 in total

1.  Morpheus and the Underworld-Interventions to Reduce the Risks of Opioid Use After Surgery: ORADEs, Dependence, Cancer Progression, and Anastomotic Leakage.

Authors:  Robert Beaumont Wilson
Journal:  J Gastrointest Surg       Date:  2019-04-01       Impact factor: 3.452

Review 2.  A systematic review of the impact of pain on overall survival in patients with cancer.

Authors:  Dylan Zylla; Grant Steele; Pankaj Gupta
Journal:  Support Care Cancer       Date:  2017-02-11       Impact factor: 3.603

Review 3.  Enhanced recovery after surgery protocols for open hepatectomy--physiology, immunomodulation, and implementation.

Authors:  Andrew J Page; Aslam Ejaz; Gaya Spolverato; Tiffany Zavadsky; Michael C Grant; Daniel J Galante; Elizabeth C Wick; Matthew Weiss; Martin A Makary; Christopher L Wu; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2014-12-04       Impact factor: 3.452

4.  Identification of shared and unique susceptibility pathways among cancers of the lung, breast, and prostate from genome-wide association studies and tissue-specific protein interactions.

Authors:  David C Qian; Jinyoung Byun; Younghun Han; Casey S Greene; John K Field; Rayjean J Hung; Yonathan Brhane; John R Mclaughlin; Gordon Fehringer; Maria Teresa Landi; Albert Rosenberger; Heike Bickeböller; Jyoti Malhotra; Angela Risch; Joachim Heinrich; David J Hunter; Brian E Henderson; Christopher A Haiman; Fredrick R Schumacher; Rosalind A Eeles; Douglas F Easton; Daniela Seminara; Christopher I Amos
Journal:  Hum Mol Genet       Date:  2015-10-19       Impact factor: 6.150

5.  Increased μ-opioid receptor expression in metastatic lung cancer.

Authors:  P A Singleton; T Mirzapoiazova; R Hasina; R Salgia; J Moss
Journal:  Br J Anaesth       Date:  2014-06-11       Impact factor: 9.166

6.  Synthesis and evaluation of a ligand targeting the μ and δ opioid receptors for drug delivery to lung cancer.

Authors:  Guo Li; Philip S Low
Journal:  Bioorg Med Chem Lett       Date:  2016-06-28       Impact factor: 2.823

7.  MOR1 expression in gastric cancer: a biomarker associated with poor outcome.

Authors:  Ya-sai Yao; Ru-yong Yao; Li-kun Zhuang; Wei-wei Qi; Jing Lv; Fei Zhou; Wen-sheng Qiu; Lu Yue
Journal:  Clin Transl Sci       Date:  2014-12-02       Impact factor: 4.689

8.  Treatment with methylnaltrexone is associated with increased survival in patients with advanced cancer.

Authors:  F Janku; L K Johnson; D D Karp; J T Atkins; P A Singleton; J Moss
Journal:  Ann Oncol       Date:  2016-08-29       Impact factor: 32.976

Review 9.  The evolution and practice of acute pain medicine.

Authors:  Justin Upp; Michael Kent; Patrick J Tighe
Journal:  Pain Med       Date:  2012-12-13       Impact factor: 3.750

10.  The effects of anesthetics on tumor progression.

Authors:  Lifang Mao; Suizhen Lin; Jun Lin
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2013-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.